Journal of Bioterrorism and Biosafety

About

About the Journal

Journal of Bioterrorism and Biosafety (JBBS) is a peer reviewed, open access Scientific Journal that publishes original research articles, review articles, case reports, short communications, etc. in all areas of Bioterrorism and Biosafety. JBBS provides complete and reliable information for scientists, clinicians, researchers, students, and general public aware of Bioterrorism with a strong focus on its effects, disorders and preventive methods.

Why publish with us

Built for researchers

⚡

Fast peer review

Target first decision within 21 days. Double-blind review by 2-3 field experts.

🔓

Fully open access

All articles CC BY 4.0. No paywalls. Compliant with funder mandates worldwide.

🔗

DOI & indexing

Every article receives a unique DOI. Indexed in PubMed, Google Scholar, CrossRef.

🚀

Rapid publication

Published within 7 days of acceptance. No unnecessary delays in dissemination.

🌐

Global & equitable

Readers in 170+ countries. Waiver program available for authors from developing nations.

📈

No content limits

No word limits. Multiple article formats: research, reviews, case reports, short communications.

How it works

Simple. Transparent. Streamlined.

Submit

Upload your manuscript via our online portal. Quality check within 48 hours.

Review

Double-blind peer review by 2-3 field experts. Target decision: ~21 days.

Revise

Constructive feedback from reviewers. Dedicated editorial support throughout.

Publish

Published within 7 days. DOI assigned via CrossRef. Globally indexed.

Submit Manuscript →

Highlights

Research Highlights

A novel recombinant vaccine protecting mice against abrin intoxication

Abrin toxin (AT) consisting of an A chain and a B chain is a potential agent for bioterrorism and an effective vaccine against AT poisoning is urgently required.

Ebolavirus and Haemorrhagic Syndrome

The Ebola virus is a highly virulent, single-stranded ribonucleic acid virus which affects both humans and apes and has fast become one of the world\'s most feared pathogens.

Point-of-care diagnostics for ricin exposure

A long-sought milestone in the defense against bioterrorism is the development of rapid, simple, and near-patient assays for diagnostic and theranostic purposes.

Preclinical testing of a vaccine candidate against tularemia

Tularemia is caused by a gram-negative, intracellular bacterial pathogen, Francisella tularensis (Ft). The history weaponization of Ft in the past has elevated concerns that it could be used as a bioweapon or an agent of bioterrorism.

GcoGSA-BA: a global core genome SNP analysis for Bacillus anthracis

As an issue of biosecurity, it is important to identify the origin of a suspected sample to distinguish whether it originated from the release of a bioterrorism agent or from environmental contamination with a virulent agent.